久久亚洲国产成人影院-久久亚洲国产的中文-久久亚洲国产高清-久久亚洲国产精品-亚洲图片偷拍自拍-亚洲图色视频

Global EditionASIA 中文雙語Fran?ais
China
Home / China / Health

Chinese scholars publish biologics guideline in international journal

By Chen Meiling | chinadaily.com.cn | Updated: 2025-05-07 20:26
Share
Share - WeChat

A Chinese guideline on the use of biologic agents in treating chronic rhinosinusitis with nasal polyps was recently published in the 2025 China Issue of Allergy, one of the most prestigious journals in the global fields of allergology and clinical immunology.

It focuses on China-specific clinical data, systematically standardizing key aspects of biologic treatment, such as patient selection, therapeutic protocols and efficacy evaluation, providing authoritative guidance for clinical practice.

"Emerging biologics that selectively target key cytokines present a promising therapeutic alternative for patients suffering from severe, uncontrollable chronic rhinosinusitis with nasal polyps," according to the guideline.

It's the first time that Chinese scholars have published a guideline-type document in a top-tier international journal in this field, offering valuable Chinese experience for global biologic applications, said Zhang Luo, president of Beijing Tongren Hospital and guest editor of the issue, at a news conference in Beijing on Wednesday.

"In the last two decades, the problems of allergic diseases have been increasing dramatically in the world. Now we are facing 2 billion patients with allergic diseases, so this is a serious threat to humankind in the future," he said.

"In the past, we primarily relied on nasal corticosteroid sprays and oral antihistamines, both of which are chemical-based medications. These treatments have been widely used and can effectively control symptoms. However, since they require frequent administration (often daily), patients may find them inconvenient. Now, with these new biologics, just about three injections over an allergy season can effectively manage symptoms. In terms of both efficacy and duration of effect, they represent an improvement over traditional treatments," Zhang said.

He said these medicines are now available in major hospitals, such as in his hospital. However, since biologics are relatively new, their cost remains high — for example, a single injection may cost around 1,000 to 2,000 yuan ($138-276). "But as their use becomes more widespread, prices are expected to gradually decrease, making them more accessible to a larger number of patients," he added.

The 2025 China Issue of Allergy includes 32 articles focusing on the latest research progress of Chinese scholars in areas such as the link between environmental pollution and asthma pathogenesis, gut microbiota dysbiosis and allergies, as well as the mechanisms underlying drug hypersensitivity.

Cezmi Akdis, editor-in-chief of the journal Allergy, the official journal of the European Academy of Allergy and Clinical Immunology, praised China's contribution to the study of allergy, which has "immensely increased" in the last two decades.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 一本久道综合久久精品 | 日韩在线视频一区二区三区 | 日本女人在线观看 | 欧美一区二区三区视频在线观看 | 久久精品免观看国产成人 | 另类欧美视频 | 97超在线 | 亚洲爽视频 | 孕妇xxxx视频在线 | 男人的天堂免费网站 | 亚洲精品国产成人99久久 | 久久精品免观看国产成人 | 2020精品极品国产色在线观看 | 一级毛片免费观看 | 国产一区二区三区视频在线观看 | 国产区久久 | 性欧美欧美巨大69 | 亚洲一级成人 | 亚洲欧美自拍一区 | 日本www高清免费视频观看 | 免费看a毛片 | 日本欧美久久久久免费播放网 | 亚洲色视频在线播放网站 | 亚洲精品久久久久中文字幕一区 | 日本一线a视频免费观看 | 91香蕉国产线观看免 | 男女乱淫真视频免费观看 | 日韩成人在线播放 | 在线免费观看国产 | 国产亚洲欧美日韩在线观看一区二区 | 国内精品小视频在线 | 国外免费一级 | 黄色三级理论片 | 九九这里只精品视在线99 | 欧美男人天堂 | 亚洲va老文色欧美黄大片人人 | 国产日韩在线视频 | 99re7在线精品免费视频 | 免费女人18毛片a级毛片视频 | 久久不雅视频 | 国产精品亚洲欧美日韩久久 |